For all cytokines examined, sample (carrier) group is not significantly different from control (baseline) group.* P(H1)—Probability of alternate hypothesis that difference between sample and control g
BackgroundSurfactant replacement therapy is the standard of care for the prevention and treatment of neonatal respiratory distress syndrome. New generation synthetic surfactants represent a promising
